Pat Bishara, 79, was diagnosed with mild cognitive impairment in late 2017. Beginning in 2021, she participated in both the phase 3 trial and the extension trial for donanemab. Along with the monthly infusion, she was also regularly evaluated by a psychologist. She had her final infusion last month. When asked about her progress, Bishara […]
FDA Commissioner Is “Excited” about New Alzheimer’s Treatment Results
Q. I remember reading about lecanemab, an Alzheimer’s treatment, in your newsletter earlier in the year. I have heard that there are other new treatments coming out to slow Alzheimer’s progression. Do you know what else is out there, and if it will be covered by Medicare? Thanks so much for your help! A. Good […]